NYSE: CLB
Core Laboratories Inc Stock

$17.61+1.19 (+7.25%)
Updated Mar 27, 2026
CLB Price
$17.61
Fair Value Price
N/A
Market Cap
$810.95M
52 Week Low
$9.72
52 Week High
$20.36
P/E
27.09x
P/B
3.05x
P/S
1.41x
PEG
3.63x
Dividend Yield
0.23%
Revenue
$526.52M
Earnings
$29.67M
Gross Margin
20.7%
Operating Margin
10.59%
Profit Margin
5.6%
Debt to Equity
1.17
Operating Cash Flow
$37M
Beta
1.12
Next Earnings
Apr 29, 2026
Ex-Dividend
N/A
Next Dividend
N/A

CLB Overview

Core Laboratories N.V. provides core and fluid analysis to the oil and gas industry to increase production from its clients' reservoirs. Specialties include basic rock properties, core analysis, and PVT characterization of reservoir fluids. Analytical and field services characterize the properties of crude oil and integrated diagnostic services evaluate the effectiveness of well completions. Core Laboratories was founded in 1936 and is based in Amstelveen, the Netherlands.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CLB's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Oil & Gas Equipment & Service

Industry Rating
B
CLB
Ranked
#19 of 47

Top Ranked Stocks in Industry

View Top Oil & Gas Equipment & Service Stocks

Be the first to know about important CLB news, forecast changes, insider trades & much more!

CLB News

Overview

Due Diligence Score

Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CLB scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CLB ($17.61) is trading above its intrinsic value of $5.12, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CLB is good value based on its earnings relative to its share price (27.09x), compared to the US market average (30.72x)
P/E vs Market Valuation
CLB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CLB due diligence checks available for Premium users.

Valuation

CLB price to earnings (PE)

For valuing profitable companies with steady earnings

Company
27.09x
Industry
32.31x
Market
30.72x
CLB is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CLB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

CLB price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
3.05x
Industry
3.06x
CLB is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CLB price to earnings growth (PEG)

For valuing profitable companies with growth potential

CLB is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

CLB's financial health

Profit margin

Revenue
$138.3M
Net Income
$4.9M
Profit Margin
3.6%
CLB's Earnings (EBIT) of $55.75M... subscribe to Premium to read more.
Interest Coverage Financials
CLB's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$584.0M
Liabilities
$311.8M
Debt to equity
1.17
CLB's short-term assets ($214.67M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CLB's short-term assets ($214.67M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CLB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CLB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$7.9M
Investing
-$3.8M
Financing
-$7.1M
CLB's operating cash flow ($37.03M)... subscribe to Premium to read more.
Debt Coverage Financials

CLB vs Oil & Gas Equipment & Service Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CLBC$810.95M+7.25%27.09x3.05x
OISB$734.52M+1.67%-6.56x1.28x
FETA$696.98M+2.72%-76.44x2.39x
FTKC$630.12M-0.17%19.36x5.57x
NGSC$501.11M+0.43%25.04x1.82x

Core Laboratories Stock FAQ

What is Core Laboratories's quote symbol?

(NYSE: CLB) Core Laboratories trades on the NYSE under the ticker symbol CLB. Core Laboratories stock quotes can also be displayed as NYSE: CLB.

If you're new to stock investing, here's how to buy Core Laboratories stock.

What is the 52 week high and low for Core Laboratories (NYSE: CLB)?

(NYSE: CLB) Core Laboratories's 52-week high was $20.36, and its 52-week low was $9.72. It is currently -13.51% from its 52-week high and 81.17% from its 52-week low.

How much is Core Laboratories stock worth today?

(NYSE: CLB) Core Laboratories currently has 46,050,433 outstanding shares. With Core Laboratories stock trading at $17.61 per share, the total value of Core Laboratories stock (market capitalization) is $810.95M.

Core Laboratories stock was originally listed at a price of $9.03 in Dec 31, 1997. If you had invested in Core Laboratories stock at $9.03, your return over the last 28 years would have been 95.02%, for an annualized return of 2.41% (not including any dividends or dividend reinvestments).

How much is Core Laboratories's stock price per share?

(NYSE: CLB) Core Laboratories stock price per share is $17.61 today (as of Mar 27, 2026).

What is Core Laboratories's Market Cap?

(NYSE: CLB) Core Laboratories's market cap is $810.95M, as of Mar 28, 2026.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Core Laboratories's market cap is calculated by multiplying CLB's current stock price of $17.61 by CLB's total outstanding shares of 46,050,433.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.